Free Trial

Adverum Biotechnologies (ADVM) Short Interest Ratio & Short Volume

Adverum Biotechnologies logo
$6.17 -0.08 (-1.28%)
(As of 11/20/2024 ET)

Adverum Biotechnologies Short Interest Data

Adverum Biotechnologies (ADVM) has a short interest of 1.60 million shares, representing 13.39% of the float (the number of shares available for trading by the public). This marks a -5.88% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.7, indicating that it would take 8.7 days of the average trading volume of 277,283 shares to cover all short positions.

Current Short Interest
1,600,000 shares
Previous Short Interest
1,700,000 shares
Change Vs. Previous Month
-5.88%
Dollar Volume Sold Short
$11.68 million
Short Interest Ratio
8.7 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
20,800,000 shares
Float Size
11,950,000 shares
Short Percent of Float
13.39%
Today's Trading Volume
221,338 shares
Average Trading Volume
277,283 shares
Today's Volume Vs. Average
80%
Short Selling Adverum Biotechnologies?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Adverum Biotechnologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ADVM Short Interest Over Time

ADVM Days to Cover Over Time

ADVM Percentage of Float Shorted Over Time

Adverum Biotechnologies Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20241,600,000 shares $11.68 million -5.9%13.4%8.7 $7.30
10/15/20241,700,000 shares $13.07 million +14.9%12.0%8.4 $7.69
9/30/20241,480,000 shares $10.39 million -9.2%10.5%5.3 $7.02
9/15/20241,630,000 shares $11.78 million +0.6%11.6%5 $7.23
8/31/20241,620,000 shares $11.24 million +8.0%11.5%5.1 $6.94
8/15/20241,500,000 shares $9.80 million +19.1%10.7%4.6 $6.53
7/31/20241,260,000 shares $9.35 million +3.3%9.7%3.3 $7.42
7/15/20241,220,000 shares $10.58 million +49.6%9.4%2.9 $8.67
6/30/2024815,800 shares $5.60 million -5.8%6.3%2.3 $6.86
6/15/2024866,200 shares $6.60 million +13.2%6.7%2.9 $7.62
5/31/2024765,100 shares $6.06 million +0.4%5.9%2.5 $7.92
5/15/2024762,200 shares $6.67 million -36.5%5.9%2.5 $8.75
4/30/20241,200,000 shares $11.66 million +6.2%8.0%4.1 $9.72
4/15/20241,130,000 shares $13.03 million +27.0%7.5%4.1 $11.53
3/31/2024890,000 shares $12.58 million +37.2%6.0%3.4 $14.14
3/15/2024648,500 shares $11.02 million -88.1%4.3%2.8 $17.00
2/29/20245,430,000 shares $10.75 million +35.4%N/A3 $1.98
2/15/20244,010,000 shares $8.02 million +228.7%4.5%2.4 $2.00
1/31/20241,220,000 shares $1.28 million -26.1%1.4%0.9 $1.05
1/15/20241,650,000 shares $1.40 million -2.4%1.9%4.4 $0.85
12/31/20231,690,000 shares $1.27 million +7.6%1.9%5.6 $0.75
12/15/20231,570,000 shares $1.28 million +5.4%1.8%5.8 $0.82
11/30/20231,490,000 shares $1.20 million No Change1.7%5.9 $0.81
11/15/20231,490,000 shares $1.31 million +10.4%1.7%6.4 $0.88
10/31/20231,350,000 shares $1.21 million +4.7%1.5%5.6 $0.90
10/15/20231,290,000 shares $1.26 million +15.2%1.5%4.6 $0.98
9/30/20231,120,000 shares $1.68 million -16.4%1.3%3.2 $1.50
9/15/20231,340,000 shares $2.09 million +20.7%1.5%3.1 $1.56
8/31/20231,110,000 shares $1.93 million +5.7%1.3%2.2 $1.74
8/15/20231,050,000 shares $1.88 million +10.5%1.2%1.9 $1.79
7/31/2023950,000 shares $2.07 million -13.6%1.0%1.8 $2.18
7/15/20231,100,000 shares $2.21 million -17.9%1.1%2.1 $2.01
6/30/20231,340,000 shares $2.13 million -14.1%1.4%2.9 $1.59
6/15/20231,560,000 shares $2.28 million +5.4%1.6%3.5 $1.46
5/31/20231,480,000 shares $1.82 million +2.8%1.5%3.4 $1.23
5/15/20231,440,000 shares $1.19 million -0.7%1.5%3.6 $0.83
4/30/20231,450,000 shares $1.14 million -4.0%1.6%3.4 $0.78
4/15/20231,510,000 shares $1.27 million -2.0%1.7%3.2 $0.84
3/31/20231,540,000 shares $1.10 million -3.1%1.7%3.5 $0.72
3/15/20231,590,000 shares $1.30 million +1.9%1.8%3 $0.82
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
2/28/20231,560,000 shares $1.12 million No Change1.7%3.3 $0.72
2/15/20231,560,000 shares $970,788.00 -0.6%1.7%2.9 $0.62
1/31/20231,570,000 shares $1.02 million -12.3%1.7%2.7 $0.65
1/15/20231,790,000 shares $1.22 million -8.2%2.0%3.2 $0.68
12/30/20221,950,000 shares $1.13 million -8.9%2.1%3.5 $0.58
12/15/20222,140,000 shares $1.35 million -11.9%2.4%3.9 $0.63
11/30/20222,430,000 shares $1.63 million No Change2.7%4.8 $0.67
11/15/20222,430,000 shares $1.70 million -5.8%2.7%4.8 $0.70
10/31/20222,580,000 shares $2.23 million -2.6%2.9%5.8 $0.87
10/15/20222,650,000 shares $2.46 million -0.4%2.9%6 $0.93
9/30/20222,660,000 shares $2.53 million +7.7%3.0%3.8 $0.95
9/15/20222,470,000 shares $2.72 million No Change2.7%2.3 $1.10
8/31/20222,470,000 shares $2.87 million -4.6%2.7%2.1 $1.16
8/15/20222,590,000 shares $3.65 million -15.4%2.9%2.1 $1.41
7/31/20223,060,000 shares $4.47 million -13.3%3.4%2.3 $1.46
7/15/20223,530,000 shares $5.82 million -12.8%3.9%2.5 $1.65
6/30/20224,050,000 shares $4.86 million -25.7%4.5%3 $1.20
6/15/20225,450,000 shares $5.29 million -4.1%6.1%4.1 $0.97
5/31/20225,680,000 shares $5.09 million +10.1%6.3%4.9 $0.90
5/15/20225,160,000 shares $4.31 million +2.8%5.8%4.8 $0.84
4/30/20225,020,000 shares $5.37 million +0.8%5.6%4.9 $1.07
4/15/20224,980,000 shares $5.98 million +3.3%5.5%4.8 $1.20
3/31/20224,820,000 shares $6.31 million +9.1%5.4%4.9 $1.31
3/15/20224,420,000 shares $5.44 million +7.8%4.9%4.3 $1.23
2/28/20224,100,000 shares $5.49 million +2.0%4.6%3.7 $1.34
2/15/20224,020,000 shares $5.71 million -14.8%4.5%3.2 $1.42
1/31/20224,720,000 shares $7.79 million -33.2%5.2%3.8 $1.65
1/15/20227,070,000 shares $11.67 million +13.7%9.4%5.3 $1.65
12/31/20216,220,000 shares $10.95 million +2.0%8.3%4.3 $1.76
12/15/20216,100,000 shares $11.29 million -14.7%8.1%3.1 $1.85
11/30/20217,150,000 shares $12.44 million +2.7%9.4%3.4 $1.74
11/15/20216,960,000 shares $15.10 million -19.7%9.2%3.4 $2.17
10/29/20218,670,000 shares $19.68 million +7.0%11.5%4.1 $2.27
10/15/20218,100,000 shares $16.69 million +6.2%10.7%3.7 $2.06
9/30/20217,630,000 shares $16.56 million -33.8%10.1%3.2 $2.17
9/15/202111,530,000 shares $25.02 million -7.5%15.2%5.9 $2.17
8/31/202112,470,000 shares $30.30 million +0.6%16.4%6.5 $2.43
8/13/202112,400,000 shares $29.02 million +2.1%16.3%5.8 $2.34
7/30/202112,150,000 shares $27.58 million +10.8%17.3%5.1 $2.27
7/15/202110,970,000 shares $34.01 million -2.1%14.7%3.3 $3.10
6/30/202111,200,000 shares $39.20 million +31.2%15.0%3.7 $3.50
6/15/20218,540,000 shares $31.26 million -10.8%11.4%3 $3.66
5/28/20219,570,000 shares $33.11 million -1.1%12.8%3.7 $3.46
5/14/20219,680,000 shares $35.04 million -21.9%N/A4.1 $3.62
4/30/202112,390,000 shares $47.45 million +6.1%N/A6 $3.83
4/15/202111,680,000 shares $107.11 million +2.8%N/A15 $9.17
3/31/202111,360,000 shares $107.35 million +11.2%N/A14 $9.45
3/15/202110,220,000 shares $109.05 million +1.7%N/A11.3 $10.67
2/26/202110,050,000 shares $125.83 million +6.2%N/A10.5 $12.52
2/12/20219,460,000 shares $131.30 million -3.6%N/A10.2 $13.88
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
1/29/20219,810,000 shares $120.37 million -4.3%N/A9.9 $12.27
1/15/202110,250,000 shares $122.54 million -0.2%N/A10.1 $11.96
12/31/202010,270,000 shares $121.19 million -13.0%N/A10.5 $11.80
12/15/202011,810,000 shares $165.46 million -4.4%N/A11.9 $14.01
11/30/202012,350,000 shares $174.14 million -5.2%N/A12 $14.10
11/15/202013,020,000 shares $164.18 million -7.1%N/A12.5 $12.61
10/30/202014,010,000 shares $157.19 million +10.1%N/A10.9 $11.22
10/15/202012,730,000 shares $150.98 million +2.7%N/A9.9 $11.86
9/30/202012,400,000 shares $127.72 million +17.7%N/A9.3 $10.30
9/15/202010,540,000 shares $135.23 million +16.6%N/A7.5 $12.83
8/31/20209,040,000 shares $110.29 million -27.9%N/A6.6 $12.20
8/14/202012,530,000 shares $166.52 million +5.7%N/A9.4 $13.29
7/31/202011,850,000 shares $198.72 million +4.0%N/A10.8 $16.77
7/15/202011,390,000 shares $205.93 million +4.2%N/A8.7 $18.08
6/30/202010,930,000 shares $226.14 million -10.3%N/A8.3 $20.69
6/15/202012,190,000 shares $288.90 million +3.0%N/A9.7 $23.70
5/29/202011,840,000 shares $240.59 million +4.0%N/A8.4 $20.32
5/15/202011,380,000 shares $205.98 million +2.9%N/A7.7 $18.10
4/30/202011,060,000 shares $131.06 million -14.5%N/A6.2 $11.85
4/15/202012,940,000 shares $144.41 million +8.8%N/A8.3 $11.16
3/31/202011,890,000 shares $154.09 million +13.7%N/A7.6 $12.96
3/13/202010,456,800 shares $116.70 million +22.0%N/A7.4 $11.16
2/28/20208,570,000 shares $88.96 million +13.7%N/A6.1 $10.38
2/14/20207,540,000 shares $76.98 million -4.1%14.6%5.5 $10.21
1/31/20207,860,000 shares $101.47 million +2.0%15.1%6.2 $12.91
1/15/20207,710,000 shares $110.72 million +6.2%14.8%7.1 $14.36
12/31/20197,260,000 shares $83.13 million -14.0%13.9%6.3 $11.45

ADVM Short Interest - Frequently Asked Questions

What is Adverum Biotechnologies' current short interest?

Short interest is the volume of Adverum Biotechnologies shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 1,600,000 shares of ADVM short. 13.39% of Adverum Biotechnologies' shares are currently sold short. Learn More on Adverum Biotechnologies' current short interest.

What is a good short interest ratio for Adverum Biotechnologies?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADVM shares currently have a short interest ratio of 9.0. Learn More on Adverum Biotechnologies's short interest ratio.

Which institutional investors are shorting Adverum Biotechnologies?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adverum Biotechnologies: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Adverum Biotechnologies?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.39% of Adverum Biotechnologies' floating shares are currently sold short.

Is Adverum Biotechnologies' short interest increasing or decreasing?

Adverum Biotechnologies saw a decrease in short interest during the month of October. As of October 31st, there was short interest totaling 1,600,000 shares, a decrease of 5.9% from the previous total of 1,700,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Adverum Biotechnologies' float size?

Adverum Biotechnologies currently has issued a total of 20,800,000 shares. Some of Adverum Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adverum Biotechnologies currently has a public float of 11,950,000 shares.

How does Adverum Biotechnologies' short interest compare to its competitors?

13.39% of Adverum Biotechnologies' shares are currently sold short. Here is how the short interest of companies compare to Adverum Biotechnologies: Coherus BioSciences, Inc. (27.35%), Black Diamond Therapeutics, Inc. (11.19%), C4 Therapeutics, Inc. (8.29%), Sangamo Therapeutics, Inc. (9.10%), Mereo BioPharma Group plc (3.26%), Zevra Therapeutics, Inc. (7.53%), ProKidney Corp. (13.64%), REGENXBIO Inc. (9.91%), Terns Pharmaceuticals, Inc. (7.17%), Esperion Therapeutics, Inc. (17.16%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Adverum Biotechnologies stock?

Short selling ADVM is an investing strategy that aims to generate trading profit from Adverum Biotechnologies as its price is falling. ADVM shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Adverum Biotechnologies?

A short squeeze for Adverum Biotechnologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ADVM, which in turn drives the price of the stock up even further.

How often is Adverum Biotechnologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADVM, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:ADVM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners